Company / Current Liabilities
FATE THERAPEUTICS INC Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$36.1M
FY2025
5-year range
$36.1M / $114.1M
FY2021-FY2025
Trend
-6.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has declined for 3 consecutive years, from $114M in FY2022 to $36M in FY2025.
Based on SEC 10-K filings.
$36M in FY2025 with a 5-year CAGR of -15.9%.
Improved from $39M to $36M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -31.9%
- 5-Year CAGR
- -15.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- FATE THERAPEUTICS INC's current liabilities has declined for 3 consecutive years.
- 5-year CAGR of -15.9%, indicating a declining trend.
- In FY2025, current liabilities decreased 6.4% year-over-year.
- Peak current liabilities was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.1M | -6.4% |
| FY2024 | $38.5M | -1.5% |
| FY2023 | $39.1M | -65.7% |
| FY2022 | $114.1M | +40.3% |
| FY2021 | $81.3M | -5.0% |
| FY2020 | $85.6M | +207.7% |
| FY2019 | $27.8M | +2.0% |
| FY2018 | $27.3M | +146.7% |
| FY2017 | $11.0M | -27.2% |
| FY2016 | $15.2M | +13.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026